Nephrocare Health Services Limited
All news and filings related to Nephrocare Health Services Limited.
View all news & filings- Medium impact
Nephroplus Subsidiary Acquires Philippine Dialysis Center Assets for ₹10.25 Crore
Nephrocare Health Services Limited's subsidiary in the Philippines is acquiring assets of a dialysis center from Renal One Dialysis Corp. The deal is valued at PhP 67,200,000, approximately ₹10.25 crore. The acquisition is part of the company's international expansion strategy.
Read the summary - Low impact
NephroPlus Grants 4,01,362 Employee Stock Options at ₹230 Each
Nephrocare Health Services Limited granted 4,01,362 Employee Stock Options under its ESOP 2026. The options are exercisable at ₹230 each and vest after a minimum of one year, subject to conditions. Each option converts to one equity share of face value ₹2.
Read the summary - Medium impact
Nephroplus Acquires 100% Stake in Kazakhstan Dialysis Center for ₹116 Crore
Nephroplus, through its subsidiary NPHSK LLP, will acquire a 100% stake in Dialysis Center Almaty LLP in Kazakhstan for KZT 561.66 million (approx. ₹116.35 million). The acquisition strengthens NEPHROPLUS's international network and presence in Kazakhstan. Completion is subject to conditions precedent.
Read the summary - Medium impact
Nephroplus Subsidiary in Uzbekistan Faces Tax Dispute of ₹14.79 Crore
Nephrocare Health Services Limited's Uzbek subsidiary, NCA, received a tax demand of approximately ₹14.79 crore, including ₹11.50 crore in net additional taxes and ₹3.29 crore as a penalty. The dispute arises from a discrepancy in revenue data impacting tax exemption eligibility. The company believes the order will not materially impact its business and is evaluating legal remedies.
Read the summary - High impact
NephroPlus Q1 FY27 Earnings Call Transcript Released, Revenue Up 23.7%
NephroPlus reported Q1 FY27 revenue growth of 23.7% to INR282 crores and adjusted EBITDA growth of 30.7% to INR65 crores. Active patients increased by 13% to 38,262, with 10.3 lakh treatments performed. The company added 26 new clinics, expanding its network to 550 clinics across 5 countries. International operations now account for 45% of revenue. The medium-term growth guidance is 15-20% annually.
Read the summary - Medium impact
Nephroplus subsidiary acquires dialysis center assets in Philippines for PhP 75 Million
Nephrocare Health Services Limited's subsidiary, Nephrocare Health Care Services, Philippines Inc., acquired assets of a dialysis center in Leyte, Philippines. The transaction, executed on August 17, 2026, was for a consideration of PhP 75,000,000.
Read the summary - Medium impact
Nephroplus Subsidiary Acquires Davao Dialysis Center Assets for PhP 71.8 Million
Nephrocare Health Services' subsidiary in the Philippines has acquired assets of a dialysis center in Davao City for PhP 71.8 million. The agreement was signed on August 12, 2026. This acquisition is part of the company's strategic expansion efforts.
Read the summary - Low impact
Nephroplus Clarifies NPHSK LLP Status: Step-Down Subsidiary, Not Wholly Owned
Nephrocare Health Services Limited clarified that NEPHROPLUS HEALTH SERVICES KAZAKHSTAN LLP (NPHSK LLP) is a step-down subsidiary, with its Singapore subsidiary holding 99% stake. NPHSK LLP aims to expand dialysis services in Kazakhstan and has a charter capital of KZT 5,000,000.
Read the summary - Low impact
Nephrocare Health Services Limited Holds 17th AGM on August 12, 2026
Nephrocare Health Services Limited conducted its 17th Annual General Meeting on August 12, 2026, via video conference. Key resolutions passed included adopting FY26 financial statements, approving the Employee Stock Option Scheme 2026, and related remuneration adjustments.
Read the summary - Low impact
Nephroplus Q1FY27 Earnings Call Audio Recording Link Disclosed
Nephrocare Health Services Limited released the audio recording of its Q1FY27 earnings call held on August 12, 2026. The call covered the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The recording is available on the company website and via a provided link.
Read the summary - Low impact
Nephroplus Monitoring Agency Report: IPO Proceeds Utilization for Q1 FY27
Nephroplus submitted its Monitoring Agency Report for Q1 FY27, detailing IPO proceeds utilization. As of June 30, 2026, ₹2,074.83 million was utilized for capital expenditure and general corporate purposes. ₹1,163.38 million remains unutilized for new dialysis clinics. There is a delay in the implementation of new clinic openings.
Read the summary - High impact
NephroPlus Q1FY27 Revenue Jumps 23.7% YoY to ₹281.8 Crore, Adj. EBITDA Up 30.7%
NephroPlus reported Q1FY27 revenue of ₹281.8 crore, up 23.7% YoY. Adjusted EBITDA increased 30.7% YoY to ₹65.1 crore, and Adjusted PAT grew 41.7% YoY to ₹36.8 crore. Treatments rose 13.3% to 10.31 lakh. The company expanded its network to 550 clinics across 5 countries.
Read the summary - High impact
NephroPlus Q1FY27 Results: Revenue up 23.7% to ₹281.8 Cr, PAT grows 41.7%
NephroPlus reported Q1FY27 revenue of ₹281.8 crore, up 23.7% YoY, with treatments up 13.3% and guests up 13.0%. Adjusted EBITDA grew 30.7% YoY to ₹65.1 crore, and Adjusted PAT increased 41.7% YoY to ₹36.8 crore. The company expanded its network to 550 clinics globally.
Read the summary - Medium impact
Nephroplus Board Approves Q1 FY27 Financials, Reconstitutes Committees, and Approves Overseas Restructuring
Nephrocare Health Services Limited reported its Q1 FY27 results. The Board approved the financial results and reconstituted the Audit and Stakeholders Relationship Committees. Additionally, an internal restructuring involving the transfer of a 51% stake in its Saudi Arabia subsidiary for Saudi Riyal 2.24 million was approved.
Read the summary - Low impact
Nephrocare Health Services to attend Investor Conference on Aug 13-14, 2026
Nephrocare Health Services Limited will attend an investor conference and non-deal roadshow from August 13-14, 2026, in Mumbai. Organized by IIFL Capital, the meetings will involve one-on-one and group discussions based on publicly available information only.
Read the summary - Low impact
Nephroplus Designated Persons Submit Trading Plans for August 2026
Nephrocare Health Services Limited announced approved trading plans from Group CEO Rohit Singh and CEO India & Nepal Sukaran Singh Saluja. Singh plans to sell 30,000 shares and Saluja plans to sell 60,000 shares between December 7-11, 2026, at a minimum price of ₹700 per share.
Read the summary - Low impact
NephroPlus Announces Q1FY27 Earnings Call on August 12, 2026
Nephrocare Health Services Limited will hold its Q1FY27 Earnings Call on August 12, 2026, at 10:00 AM IST. Management will discuss unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. No UPSI will be disclosed.
Read the summary - Low impact
Nephroplus Announces 17th AGM on Aug 12, 2026, with Remote E-voting Facility
Nephrocare Health Services Limited will hold its 17th AGM on August 12, 2026, via video conference. Remote e-voting is available from August 8 to August 11, 2026. The Annual Report for FY 2025-26 has been shared with shareholders.
Read the summary - Low impact
Nephroplus Dispatches Annual Report FY26 & AGM Notice; AGM on Aug 12
Nephroplus dispatched its Annual Report FY26 and AGM Notice on July 16, 2026. The 17th AGM is scheduled for August 12, 2026, at 2:30 PM IST via VC/OAVM. The cut-off date is August 5, 2026, with remote e-voting from August 8 to August 11, 2026.
Read the summary - Medium impact
Nephrocare Health Services to hold 17th AGM on Aug 12, 2026, for financial year 2025-26 results and ESOP approval
Nephrocare Health Services will hold its 17th AGM on August 12, 2026, to adopt FY26 financial statements and approve the ESOP 2026 plan. The AGM will cover re-appointment of a director and a clarificatory amendment to the CMD's remuneration. Remote e-voting is open from August 8-11, 2026.
Read the summary - Low impact
Nephroplus Announces 17th AGM via VC/OAVM, Sets Cut-Off Date for E-voting
Nephrocare Health Services Limited will hold its 17th AGM on August 12, 2026, via VC/OAVM. The cut-off date for e-voting eligibility is August 5, 2026. Annual reports will be shared electronically. NSDL will facilitate e-voting.
Read the summary - Low impact
NephroPlus Allots 2,18,297 Equity Shares Under ESOP Scheme 2011
Nephrocare Health Services Limited has allotted 2,18,297 equity shares under its ESOP Scheme 2011. This allotment increases the company's paid-up equity share capital to ₹20,11,18,028. The exercise of these stock options generated ₹2,08,18,944.35. In-principal listing approvals have been received from NSE and BSE.
Read the summary - Medium impact
Nephrocare provides USD 3.3 Mn (₹31.22 Cr) collateral for subsidiary NHSI
Nephrocare Health Services Limited has provided collateral support of USD 3,300,000 (₹31.22 Crore) to its subsidiary, NHSI, Singapore. This enables NHSI to avail credit facilities from Citibank. The commitment creates a contingent financial exposure for Nephrocare.
Read the summary - Medium impact
Nephroplus Subsidiary Acquires Philippine Dialysis Center Assets for PhP 80.64 Million
Nephrocare Health Services Limited's subsidiary, Nephrocare Health Care Services, Philippines Inc., acquired assets of a dialysis center in the Philippines from Pag-Asa Dialysis And Diagnostic Center. The transaction, dated June 22, 2026, has a total consideration of PhP 80,640,000.
Read the summary - Low impact
Nephroplus Closes Trading Window from June 22 for Q1 FY27 Financial Results
Nephrocare Health Services Limited will close its trading window from June 22, 2026. This is due to unpublished price-sensitive information regarding the financial results for the quarter ending June 30, 2026. The window will reopen 48 hours after the results are declared.
Read the summary - Low impact
Edoras Investment Holdings Pte. Ltd. Declares No New Share Encumbrances for FY26
Edoras Investment Holdings Pte. Ltd. has declared that no new encumbrances were created on Nephrocare Health Services Limited shares during FY26. This is an annual declaration under SEBI Takeover Regulations, confirming no new pledges beyond previously disclosed ones.
Read the summary - Low impact
Nephroplus Cancels Analyst/Investor Meetings Scheduled for June 18-19, 2026
Nephrocare Health Services Limited has cancelled its participation in the HSBC Singapore Conference. The Analyst/Institutional Investor Meetings scheduled for June 18-19, 2026, are cancelled due to unforeseen circumstances. This cancellation follows a prior intimation about the meetings.
Read the summary - Low impact
Healthcare Parent Limited Declares No New Share Encumbrance for FY26
Healthcare Parent Limited, promoter of Nephrocare Health Services Limited, declared no new share encumbrances for the financial year ended March 31, 2026. This annual declaration was submitted under SEBI Takeover Regulations.
Read the summary - Low impact
Nephroplus to Hold Investor Meet with Elara Capital on June 16, 2026, in Tirupati
Nephrocare Health Services Limited will hold an investor meeting with Elara Capital on June 16, 2026, in Tirupati. The meeting will focus on publicly available information, with no UPSI to be discussed. Changes to the schedule are possible.
Read the summary - Low impact
Bessemer Venture Partners Trust Confirms No New Encumbrances on NEPHROPLUS Shares for FY26
Bessemer Venture Partners Trust, a promoter of Nephrocare Health Services Limited, declared that no new encumbrances were created on the company's shares during the financial year ended March 31, 2026. This annual declaration is in compliance with SEBI Takeover Regulations.
Read the summary - Medium impact
Nephroplus Subsidiary Acquires Dialysis Center Assets in Philippines for PhP 32.64 Million
Nephrocare Health Services Limited's subsidiary in the Philippines has signed an Asset Transfer Agreement to acquire dialysis center assets for PhP 32.64 million. The acquisition is by Nephrocare Health Care Services, Philippines Inc. from Amica Healthcare System Corporation. The deal is valued at approximately ₹2.4 crore.
Read the summary - Medium impact
Nephroplus Subsidiary Acquires Philippine Dialysis Center Assets for PHP 30 Million
Nephrocare Health Services Limited's subsidiary, Nephrocare Health Care Services, Philippines Inc., acquired assets of a dialysis center in Quezon City, Philippines, for PHP 30 million via an Asset Transfer Agreement.
Read the summary - High impact
NephroPlus Q4 & FY26 Earnings Call Transcript Released; FY26 Revenue Rs 998.8 Cr, Up 32%
NephroPlus released its Q4 & FY26 earnings call transcript. For FY26, revenue grew 32% to ₹998.8 crore, and PAT grew 75% to ₹128.3 crore. Active patients increased by 12% to 37,000, with treatments up 17% to 38.4 lakh. The company maintains a 15-20% revenue CAGR guidance for the next 3-4 years. Two PPP contracts are up for renewal in 2026.
Read the summary - Low impact
Nephroplus to attend Investor Conference hosted by Choice Broking on June 11, 2026
Nephrocare Health Services Limited will attend a virtual investor conference hosted by Choice Broking on June 11, 2026. The meeting will focus on publicly available information, with no unpublished price-sensitive information to be disclosed. The event is scheduled to commence at 11:00 AM IST.
Read the summary - Low impact
Nephroplus to attend BoFA Healthcare Tour investor meeting on June 4
Nephrocare Health Services Limited will attend a Bank of America hosted investor meeting on June 4, 2026, in Hyderabad as part of the BoFA Healthcare Tour. Discussions will be limited to publicly available information.
Read the summary - Medium impact
Nephroplus Incorporates Wholly-Owned Subsidiary in Kazakhstan to Expand Healthcare Network
Nephrocare Health Services Limited has incorporated a new wholly-owned subsidiary, NPHSK LLP, in Kazakhstan on May 26, 2026. The subsidiary aims to expand the company's kidney care and dialysis services network in the region. The initial charter capital is KZT 5,000,000 (approx. USD 10,500).
Read the summary - Low impact
Nephroplus to Attend HSBC Investor Conference on June 18-19, 2026
Nephrocare Health Services Limited (NEPHROPLUS) officials will attend an investor conference hosted by HSBC Singapore on June 18-19, 2026, in Mumbai. The meetings will focus on publicly available information. Schedules are subject to change.
Read the summary - Low impact
Nephroplus to Attend Investor Conference on June 15-16, 2026
Nephrocare Health Services Limited officials will attend an investor conference. The Non-Deal Roadshow, hosted by Citi Group / 1*1 Meetings, is scheduled for June 15-16, 2026, in Mumbai. Discussions will be limited to publicly available information.
Read the summary - Medium impact
Nephroplus Acquires Two Dialysis Centers in Philippines for ₹11.24 Crore
Nephrocare Health Services Limited's subsidiary acquired two dialysis centers in the Philippines. The total consideration for these acquisitions amounts to approximately ₹11.24 Crores. One center was acquired from Northern Mindanao Dialysis Clinic Inc. for ₹4.25 Crore, and the other from Aliaga Hemodialysis Centre Inc. for ₹6.99 Crore.
Read the summary - Low impact
Nephrocare Health Services to attend Axis Capital Investor Conference on June 2, 2026
Nephrocare Health Services Limited will attend an investor conference hosted by Axis Capital on June 2, 2026, in Mumbai. The meeting will focus on publicly available information. No unpublished price-sensitive information will be discussed.
Read the summary - Low impact
Nephroplus Releases Audio Recording of Q4 & FY26 Financial Results Investor Conference Call
Nephrocare Health Services Limited released the audio recording of its investor conference call on May 20, 2026. The call covered the audited standalone and consolidated financial results for Q4 and FY26, ending March 31, 2026. The recording is available on the company website.
Read the summary - Medium impact
Nephrocare Health Services Approves Investments & Guarantees; FY26 Results
Nephrocare Health Services board approved audited financial results for FY26. It will invest up to ₹10 Crore in its Nepal subsidiary and provide up to ₹70 Crore in collateral support each for its Singapore and Saudi Arabia subsidiaries to enable credit facilities. M/s. BDO India LLP was re-appointed as Internal Auditor for FY27. The board meeting concluded on May 19, 2026.
Read the summary - High impact
Nephrocare Health Services FY26 Revenue at ₹998.8 Cr, Up 32.2% YoY
Nephrocare Health Services reported a 32.2% YoY increase in FY26 revenue, reaching ₹998.8 crore. Adjusted EBITDA rose by 37.6% to ₹238.1 crore, and adjusted PAT increased by 74.6% to ₹128.3 crore. Q4 FY26 revenue grew by 21.2% YoY to ₹265.6 crore. The company served 36,981 guests and saw a 16.6% increase in treatments. International markets contributed significantly to revenue growth.
Read the summary - High impact
Nephrocare Health Services FY26 Revenue Up 32.2% to ₹998.8 Crore
Nephrocare Health Services (NEPHROPLUS) reported a 32.2% YoY increase in FY26 revenue, reaching ₹998.8 crore. Adjusted EBITDA rose 37.6% to ₹238.1 crore. Treatment volumes grew by 16.6% YoY. The company's international revenue contribution increased from 31.8% to 41.8%. Vikram Vuppala and Rohit Singh commented on the company's growth and strategic focus.
Read the summary - Medium impact
Nephrocare Health Services Approves ₹10 Crore Investment in Nepal Subsidiary
Nephrocare Health Services board approved audited financial results for the year ended March 31, 2026. A further investment of up to ₹10 crore in its Nepal subsidiary was approved. Collateral/security support of up to ₹70 crore each was approved for Singapore and Saudi Arabia subsidiaries to enable credit facilities. M/s. BDO India LLP was re-appointed as Internal Auditor for FY27.
Read the summary - Low impact
Nephroplus IPO Proceeds Utilized for Capex, Debt Repayment, and General Corporate Purposes in Q4 FY26
Nephrocare Health Services Limited's IPO proceeds for Q4 FY26 were utilized for capital expenditure, debt repayment, and general corporate purposes. ₹904.99 million was used for debt repayment and other expenses during the quarter. Unutilized funds amount to ₹1,777.51 million. A delay in new dialysis clinic openings was noted.
Read the summary - Medium impact
Nephroplus Acquires Dialysis Center Assets in Philippines for PHP 8.96 Crore
Nephrocare Health Services' subsidiary has acquired dialysis center assets in the Philippines from Orani Hemodialysis Center Inc. for PHP 89,600,000.00 (approx. ₹12.8 crore). The agreement was signed on May 12, 2026.
Read the summary - Low impact
Nephrocare Health Services Files SEBI Compliance Certificate for Q4 FY26
Nephrocare Health Services Limited filed a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The certificate was received from Registrar and Share Transfer Agent, KFIN Technologies Limited, confirming dematerialization/rematerialization details were submitted to stock exchanges.
Read the summary - Medium impact
Nephrocare Health Services Appoints Prashant Vinodkumar Goenka as Chief Risk Officer
Nephrocare Health Services Limited designated Mr. Prashant Vinodkumar Goenka as Chief Risk Officer, effective April 03, 2026. He continues as CFO. Goenka, with over 20 years of financial services experience, joined the company on May 7, 2024.
Read the summary - Low impact
Nephroplus Files Writ Petition Against GST Orders Demanding ₹2.51 Crore
Nephrocare Health Services Limited filed a writ petition on April 02, 2026, challenging GST orders. The company disputes a demand of ₹2.51 crore (₹1.46 crore tax, ₹0.90 crore interest, ₹0.15 crore penalty) related to FY 2020-21. The company believes the demand is not tenable and expects no material impact.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio